Interest of hair tests to discriminate a tail end of a doping regimen from a possible contamination in case of challenging an anti‐doping rule violation. V. Case reports involving trimetazidine, a drug where the concentration after a single 20 mg dose has been established
Open Access
- 1 August 2024
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 17 (6) , 779-785
Abstract
The identification of trimetazidine, a medicine used for treating stable angina pectoris and for preventing angina attacks, has been recently observed in doping cases involving high profile athletes from various countries over the world. In all the files where the authors have been involved, the urine concentration of trimetazidine was low (no fault or negligence. When the delay between the urine collection and the notification of the violation was not too long (less than 6 months), these athletes requested a head hair test. Trimetazidine was analyzed by an original LC–MS/MS method involving pH 9.5 borate buffer overnight incubation of 20 mg and subsequent solvents extraction in presence of trimetazidine‐D8 used as internal standard. Linearity was verified from 1 to 200 pg/mg (R2 = 0.9987). Limit of detection of the method was 0.1 pg/mg. The hair specimen of a male subject, collected 4 weeks after single oral ingestion of 20 mg trimetazidine, tested positive at 146 pg/mg in the corresponding segment. Concentrations of trimetazidine measured in several hair specimens (n = 5) collected from athletes challenging their anti‐doping rule violation were below 1 pg/mg, which is consistent with incidental exposure due to contamination. This is the first evidence that trimetazidine is incorporated in human hair after a single therapeutic dose administration.Keywords
This publication has 17 references indexed in Scilit:
- Violation des règles antidopage et contamination. Stratégie de défense des athlètes à partir d’une analyse de cheveux et considérations généralesToxicologie Analytique et Clinique, 2024
- Elimination profile of low‐dose chlortalidone and its detection in hair for doping analysis—Implication for unintentional non‐therapeutic exposureDrug Testing and Analysis, 2024
- Hair and dietary supplements testing to identify contamination with roxadustat in an adverse analytical findingJournal of Pharmaceutical and Biomedical Analysis, 2023
- Sports drug testing and the athletes' exposomeDrug Testing and Analysis, 2021
- La trimétazidine (Vastarel) est-elle un produit dopant ? Proposition pour une suppression de la liste des produits interdits de l’Agence mondiale anti-dopageToxicologie Analytique et Clinique, 2020
- Hair testing for doping agents. What is known and what remains to doDrug Testing and Analysis, 2020
- Hair analysis to discriminate voluntary doping vs inadvertent ingestion of the aromatase inhibitor letrozoleDrug Testing and Analysis, 2018
- The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administrationDrug Testing and Analysis, 2014
- Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approachesDrug Testing and Analysis, 2014
- Sensitive and rapid LC–ESI-MS method for the determination of trimetazidine in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2007